Advertisement
Loading...

Micro-X Limited

MX1.AXASX
Healthcare
Medical - Devices
$0.04
$-0.00(-2.22%)
Australian Market opens in 2h 41m
Advertisement

Micro-X Limited Fundamental Analysis

Micro-X Limited (MX1.AX) shows weak financial fundamentals with a PE ratio of -2.55, profit margin of -75.07%, and ROE of -1.80%. The company generates $0.0B in annual revenue with weak year-over-year growth of -14.25%.

Key Strengths

Cash Position16.62%
PEG Ratio0.41

Areas of Concern

ROE-1.80%
Operating Margin-83.39%
We analyze MX1.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -232.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-232.5/100

We analyze MX1.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

MX1.AX struggles to generate sufficient returns from assets.

ROA > 10%
-67.95%

Valuation Score

Excellent

MX1.AX trades at attractive valuation levels.

PE < 25
-2.55
PEG Ratio < 2
0.41

Growth Score

Weak

MX1.AX faces weak or negative growth trends.

Revenue Growth > 5%
-14.25%
EPS Growth > 10%
-23.24%

Financial Health Score

Excellent

MX1.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.92
Current Ratio > 1
1.45

Profitability Score

Weak

MX1.AX struggles to sustain strong margins.

ROE > 15%
-180.06%
Net Margin ≥ 15%
-75.07%
Positive Free Cash Flow
No

Key Financial Metrics

Is MX1.AX Expensive or Cheap?

P/E Ratio

MX1.AX trades at -2.55 times earnings. This suggests potential undervaluation.

-2.55

PEG Ratio

When adjusting for growth, MX1.AX's PEG of 0.41 indicates potential undervaluation.

0.41

Price to Book

The market values Micro-X Limited at 5.39 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.39

EV/EBITDA

Enterprise value stands at -2.42 times EBITDA. This is generally considered low.

-2.42

How Well Does MX1.AX Make Money?

Net Profit Margin

For every $100 in sales, Micro-X Limited keeps $-75.07 as profit after all expenses.

-75.07%

Operating Margin

Core operations generate -83.39 in profit for every $100 in revenue, before interest and taxes.

-83.39%

ROE

Management delivers $-1.80 in profit for every $100 of shareholder equity.

-1.80%

ROA

Micro-X Limited generates $-67.95 in profit for every $100 in assets, demonstrating efficient asset deployment.

-67.95%

Following the Money - Real Cash Generation

Operating Cash Flow

Micro-X Limited generates limited operating cash flow of $-10.59M, signaling weaker underlying cash strength.

$-10.59M

Free Cash Flow

Micro-X Limited generates weak or negative free cash flow of $-10.64M, restricting financial flexibility.

$-10.64M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

MX1.AX converts -29.76% of its market value into free cash.

-29.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.55

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.41

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.92

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.45

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.80

vs 25 benchmark

ROA

Return on assets percentage

-0.68

vs 25 benchmark

ROCE

Return on capital employed

-1.53

vs 25 benchmark

How MX1.AX Stacks Against Its Sector Peers

MetricMX1.AX ValueSector AveragePerformance
P/E Ratio-2.5529.06 Better (Cheaper)
ROE-180.06%733.00% Weak
Net Margin-75.07%-53111.00% (disorted) Weak
Debt/Equity0.920.38 Weak (High Leverage)
Current Ratio1.454.02 Neutral
ROA-67.95%-19397.00% (disorted) Weak

MX1.AX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Micro-X Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

16.51%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

47.63%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

65.53%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ